Efeitos dos exercícios de amplitude de movimento mandibular e terapia de deglutição na qualidade de vida dos pacientes em tratamento de câncer de cabeça e pescoço: uma revisão sistemática
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Head and neck cancer (HNC) treatment can lead to functional sequelae, such as trismus and
dysphagia, compromising patients' quality of life (QoL). Although mandibular
range-of-motion exercises (MROME) and swallowing therapy are widely used to rehabilitate
these complications, their impact on QoL remains uncertain. In this context, this systematic
review aimed to evaluate the effects of these interventions on the QoL of patients with trismus
and/or dysphagia resulting from HNC treatment. The review was conducted according to
Cochrane Handbook recommendations, registered in PROSPERO, and reported in
compliance with the PRISMA 2020 statement. Searches were performed in the PubMed,
EMBASE, Cochrane Library, LILACS, Scopus, and Web of Science databases and
supplemented by a search of grey literature, with no language or publication date restrictions.
Risk of bias was assessed using the RoB 2 tool, and the certainty of evidence was evaluated
using the GRADE. A total of eight randomized controlled trials (RCTs) comparing MROME
and/or swallowing therapy with usual care were included. Overall, the results demonstrated
benefits regarding specific functional outcomes, particularly increased mouth opening,
improved swallowing, and reduced emotional distress. Conversely, no consistent
improvement was observed in global QoL or in the physical, social, and functional well-being
domains. Furthermore, high clinical and methodological heterogeneity among the studies,
combined with small sample sizes and risk of bias, precluded a meta-analysis and resulted in
the evidence for the QoL outcome being classified as very low certainty. In summary,
MROME and swallowing therapy show potential for improving functional aspects of
rehabilitation for patients with trismus and/or dysphagia following HNC treatment. However,
current evidence remains insufficient to demonstrate consistent benefits regarding global
QoL. Thus, future studies with greater methodological rigor, standardized protocols, and more
representative samples are needed to generate more robust evidence and inform clinical
practice.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

